(Re)Appraising Remission in Ulcerative Colitis

Inflamm Bowel Dis. 2023 Aug 1;29(8):1317-1326. doi: 10.1093/ibd/izac170.


Ajit Sood 1Arshdeep Singh 1Ramit Mahajan 1Vandana Midha 2Charles N Bernstein 3David T Rubin 4


Author information

1Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

2Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

3IBD Clinical and Research Centre and Section of Gastroenterology, Department of Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

4Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.


As the therapeutic targets in ulcerative colitis (UC) shift from control of symptoms to mucosal healing and prevention of disease complications like disability, colectomy, and cancer, the definition of remission has evolved. The current definition of clinical remission is variable and is determined by the clinical context in which it is being used. This results in skepticism and uncertainty about the true meaning of the term "clinical remission." In this review, the authors reexamine the definition of clinical remission and propose a novel approach to define remission in UC.

© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.